{"id":22335,"date":"2014-05-15T07:17:10","date_gmt":"2014-05-15T11:17:10","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=22335"},"modified":"2014-05-15T07:17:10","modified_gmt":"2014-05-15T11:17:10","slug":"abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335","title":{"rendered":"Abbott Laboratories (NYSE:ABT) Knocks Morgan Stanley&#8217;s Doors For The Sell of Established Drugs"},"content":{"rendered":"<p>Boston, MA 05\/15\/2014 (wallstreetpr) \u2013\u00a0<b>Abbott Laboratories (NYSE:ABT) <\/b>is a leading name in the field of women&#8217;s health, neurology, gastroenterology, thyroid, vitamins, diabetes &amp; urology pain management, anti-infective &amp;\u00a0 several other therapies. Recently the news came out that the company is seeking the help of Morgan Stanley for the selling of established drugs.<\/p>\n<p>&nbsp;<\/p>\n<p><b>Matter in Detail<\/b>:<\/p>\n<p>Abbott Laboratories (NYSE:ABT)<b> <\/b>has a large stock of mature drugs available with it and looks forward to selling the complete stock so that the company can focus on other areas as well. The complete stock of drugs available with ABT can earn more than $2 billion annually and$5 billion in total, said one of the persons familiar with this issue.<\/p>\n<p>Please note that ABT is a big name in the field of drug making. It is quite active in the production of drugs like Similac infant formula, and PediaSure. The company is looking to find a buyer who can buy the complete stock of the drugs available with the company, and because the company has decided to take the help of Morgan Stanley. This information was made public by a person very close to the management of the company who denied to reveal his identity as the matter is very private and personal.<\/p>\n<p>Abbott Laboratories (NYSE:ABT)<b> <\/b>has a huge stock of various pharmaceuticals whose sell had fallen significantly in last one year. Please note that the total reduction in the sales was recorded as 3% that was more than ever. Due to this decline in the sales, the company managed to record sales of only $4.97 billion that was quite less as far as past sales records are concerned.<\/p>\n<p>Even after this negative performance, the CEO of Abbott Laboratories (NYSE:ABT), Miles White believes that the coming months will bring new opportunities for the company in the areas of research and other operations. Everyone will get to see a clear picture in the coming months.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 05\/15\/2014 (wallstreetpr) \u2013\u00a0Abbott Laboratories (NYSE:ABT) is a leading name in the field of women&#8217;s health, neurology, gastroenterology, thyroid, vitamins, diabetes &amp; urology pain [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":15459,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[3448,1125],"stock_ticker":[],"class_list":["post-22335","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-abbott-laboratories-nyseabt","tag-nyseabt","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Abbott Laboratories (NYSE:ABT) Knocks Morgan Stanley&#039;s Doors For The Sell of Established Drugs - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abbott Laboratories (NYSE:ABT) Knocks Morgan Stanley&#039;s Doors For The Sell of Established Drugs - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 05\/15\/2014 (wallstreetpr) \u2013\u00a0Abbott Laboratories (NYSE:ABT) is a leading name in the field of women&#8217;s health, neurology, gastroenterology, thyroid, vitamins, diabetes &amp; urology pain [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-05-15T11:17:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/AbbottLaboratories.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Abbott Laboratories (NYSE:ABT) Knocks Morgan Stanley&#8217;s Doors For The Sell of Established Drugs\",\"datePublished\":\"2014-05-15T11:17:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335\"},\"wordCount\":334,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/AbbottLaboratories.jpg\",\"keywords\":[\"Abbott Laboratories (NYSE:ABT)\",\"NYSE:ABT\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335\",\"name\":\"Abbott Laboratories (NYSE:ABT) Knocks Morgan Stanley's Doors For The Sell of Established Drugs - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/AbbottLaboratories.jpg\",\"datePublished\":\"2014-05-15T11:17:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/AbbottLaboratories.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/AbbottLaboratories.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abbott Laboratories (NYSE:ABT) Knocks Morgan Stanley&#8217;s Doors For The Sell of Established Drugs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abbott Laboratories (NYSE:ABT) Knocks Morgan Stanley's Doors For The Sell of Established Drugs - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335","og_locale":"en_US","og_type":"article","og_title":"Abbott Laboratories (NYSE:ABT) Knocks Morgan Stanley's Doors For The Sell of Established Drugs - Wall Street PR","og_description":"Boston, MA 05\/15\/2014 (wallstreetpr) \u2013\u00a0Abbott Laboratories (NYSE:ABT) is a leading name in the field of women&#8217;s health, neurology, gastroenterology, thyroid, vitamins, diabetes &amp; urology pain [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-05-15T11:17:10+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/AbbottLaboratories.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Abbott Laboratories (NYSE:ABT) Knocks Morgan Stanley&#8217;s Doors For The Sell of Established Drugs","datePublished":"2014-05-15T11:17:10+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335"},"wordCount":334,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/AbbottLaboratories.jpg","keywords":["Abbott Laboratories (NYSE:ABT)","NYSE:ABT"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335","url":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335","name":"Abbott Laboratories (NYSE:ABT) Knocks Morgan Stanley's Doors For The Sell of Established Drugs - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/AbbottLaboratories.jpg","datePublished":"2014-05-15T11:17:10+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/AbbottLaboratories.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/AbbottLaboratories.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbott-laboratories-nyseabt-knocks-morgan-stanleys-doors-for-the-sell-of-established-drugs-22335#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Abbott Laboratories (NYSE:ABT) Knocks Morgan Stanley&#8217;s Doors For The Sell of Established Drugs"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/22335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=22335"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/22335\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/15459"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=22335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=22335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=22335"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=22335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}